Community-acquired methicillin-resistant Staphylococcus aureus infections requiring admission to a Tunisian pediatric

Khaled Menif1, Asma Bouziri, Ammar Khaldi

  • 1Pediatric Intensive Care Unit, Children's Hospital of Tunis, Tunisia.

La Tunisie Medicale
|November 15, 2011
PubMed

Insights

Severe community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in children are rare but serious. This study reviews 14 pediatric intensive care unit cases, finding pneumonia and septic shock common, with lower mortality than previously reported.

Area of Science:

  • Pediatric Infectious Diseases
  • Intensive Care Medicine
  • Microbiology

Background:

  • Limited literature exists on severe community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in pediatric intensive care units.
  • CA-MRSA is a significant pathogen in community-acquired infections.

Purpose of the Study:

  • To describe the clinical features and outcomes of children with CA-MRSA admitted to a Tunisian pediatric intensive care unit.
  • To assess the presentation and severity of CA-MRSA infections in a pediatric intensive care setting.

Main Methods:

  • Retrospective chart review of patients diagnosed with CA-MRSA over a 10-year period.
  • Analysis of clinical data, including patient demographics, clinical presentation, and outcomes.

Main Results:

  • Fourteen cases of severe CA-MRSA were identified, representing 0.32% of admissions.
  • Pulmonary involvement was universal, with 42.8% experiencing septic shock and 14.3% developing deep venous thrombosis.
  • The mortality rate was 14.3%.

Conclusions:

  • Severe CA-MRSA pneumonia was the predominant clinical presentation in this cohort.
  • The observed mortality rate for CA-MRSA infection in this series is lower than previously reported in the literature.
Abstract

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...